Individualized Homeopathic Medicines in Stage I Essential Hypertension: A Double-Blind, Randomized, Placebo-Controlled Pilot Trial

被引：2

作者：

Sadhukhan, Satarupa ^{[1
]}

Singh, Subhas ^{[2
]}

Michael, James ^{[1
]}

Misra, Pankhuri ^{[3
]}

Parewa, Maneet ^{[4
]}

Nath, Arunava ^{[1
]}

Magotra, Nitin ^{[1
]}

Kundu, Nivedita ^{[1
]}

Basu, Anamika ^{[5
]}

Ali, Sk Swaif ^{[5
]}

Koley, Munmun ^{[6
]}

Saha, Subhranil ^{[7
]}

机构：

[1] Natl Inst Homoeopathy, Dept Organon Med & Homoeopath Philosophy, Kolkata, India

[2] Natl Inst Homoeopathy, Kolkata, India

[3] Natl Inst Homoeopathy, Dept Mat Med, Kolkata, India

[4] Natl Inst Homoeopathy, Dept Repertory, Kolkata, India

[5] Mahesh Bhattacharyya Homoeopath Med Coll & Hosp, Dept Practice Med, Govt West Bengal, Howrah, India

[6] State Natl Homoeopath Med Coll & Hosp, Dept Organon Med & Homoeopath Philosophy, Govt Uttar Pradesh, Lucknow, Uttar Pradesh, India

[7] DN Homoeopath Med Coll & Hosp, Dept Repertory, Govt West Bengal, Kolkata, India

来源：

JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE | 2021年 / 27卷 / 06期

关键词：

essential hypertension; homeopathy; placebo; pilot trial; randomized controlled trial; BLOOD-PRESSURE; PUBLICATION; DRUG;

D O I：

10.1089/acm.2020.0222

中图分类号：

R [医药、卫生];

学科分类号：

10 ;

摘要：

Objective: The present study assessed the feasibility of a definitive placebo-controlled trial for evaluating individualized homeopathy (IH) in stage I hypertension (HTN). Design: Double-blind, randomized (IH: 34, placebo: 34), placebo-controlled, parallel arms, pilot trial. Settings/Location: National Institute of Homoeopathy, India. Subjects: Patients suffering from stage I HTN. Interventions: IH and identical-looking placebo. Outcome measures: Feasibility issues, blood pressure (BP) and Measure Yourself Medical Outcome Profile-2 (MYMOP-2) were assessed for 6 months. Results: The recruitment and retention rates were 44.4% and 85.3%, respectively. Group differences were seemingly higher in the IH group than in the placebo group. Conclusions: Despite challenges in recruitment, an adequately powered efficacy trial appears feasible in the future.

引用

页码：515 / 521

页数：7

共 50 条

[41] Topiramate in essential tremor - A double-blind, placebo-controlled trial
Ondo, WG
Jankovic, J
Connor, GS
Pahwa, R
Elble, R
Stacy, MA
Koller, WC
Schwarzman, L
Wu, SC
Hulihan, JF
[J]. NEUROLOGY, 2006, 66 (05) : 672 - 677
[42] Homeopathic treatment of mild traumatic brain injury: A randomized, double-blind, placebo-controlled clinical trial
Chapman, EH
Weintraub, RJ
Milburn, MA
Pirozzi, TO
Woo, E
[J]. JOURNAL OF HEAD TRAUMA REHABILITATION, 1999, 14 (06) : 521 - 542
[43] Randomized, placebo-controlled, double-blind pilot trial of ramipril in McArdle's disease
Martinuzzi, Andrea
Liava, Alexandra
Trevisi, Enrico
Frare, Mara
Tonon, Caterina
Malucelli, Emil
Manners, David
Kemp, Graham J.
Testa, Claudia
Barbiroli, Bruno
Lodi, Raffaele
[J]. MUSCLE & NERVE, 2008, 37 (03) : 350 - 357
[44] A randomized, double-blind, placebo-controlled pilot trial of triiodothyronine in neonatal heart surgery
Mackie, AS
Booth, KL
Newburger, JW
Gauvreau, K
Huang, SA
Laussen, PC
DiNardo, JA
del Nido, PJ
Mayer, JE
Jonas, RA
McGrath, E
Elder, J
Roth, SJ
[J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (03): : 810 - 816
[45] Topiramate for the management of methamphetamine dependence: a pilot randomized, double-blind, placebo-controlled trial
Rezaei, Farzin
Ghaderi, Ebrahim
Mardani, Roya
Hamidi, Seiran
Hassanzadeh, Kambiz
[J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (03) : 282 - 289
[46] Progesterone and Postpartum Smoking Relapse: A Pilot Double-Blind Placebo-Controlled Randomized Trial
Allen, Sharon S.
Allen, Alicia M.
Lunos, Scott
Tosun, Nicole
[J]. NICOTINE & TOBACCO RESEARCH, 2016, 18 (11) : 2145 - 2153
[47] Marfan Sartan: a randomized, double-blind, placebo-controlled trial
Milleron, Olivier
Arnoult, Florence
Ropers, Jacques
Aegerter, Philippe
Detaint, Delphine
Delorme, Gabriel
Attias, David
Tubach, Florence
Dupuis-Girod, Sophie
Plauchu, Henry
Barthelet, Martine
Sassolas, Francois
Pangaud, Nicolas
Naudion, Sophie
Thomas-Chabaneix, Julie
Dulac, Yves
Edouard, Thomas
Wolf, Jean-Eric
Faivre, Laurence
Odent, Sylvie
Basquin, Adeline
Habib, Gilbert
Collignon, Patrick
Boileau, Catherine
Jondeau, Guillaume
[J]. EUROPEAN HEART JOURNAL, 2015, 36 (32) : 2160 - U37
[48] A randomized, double-blind, placebo-controlled trial of pseudoephedrine in coryza
Latte, J
Taverner, D
Slobodian, P
Shakib, S
[J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2004, 31 (07): : 429 - 432
[49] A double-blind, randomized, placebo-controlled laser trial methodology
Oussedik, E.
Saleem, M. D.
Patel, N. U.
Feldman, S. R.
[J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2017, 137 (10) : B11 - B11
[50] A double-blind, placebo-controlled, pilot study of mirtazapine in essential tremor
Lyons, KE
Pahwa, R
[J]. NEUROLOGY, 2002, 58 (07) : A254 - A254

← 1 2 3 4 5 →